Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
Daniel Q Holland, Joshua J NeumillerDepartment of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USAAbstract: Alogliptin is a selective dipeptidyl peptidase-4 inhibitor recently marketed for once-daily administration in the treatment of type 2 diabetes melli...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/53402642e95245d494c8940a9115b18a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!